National clinical directors and specialty advisers
The National Clinical Directors and National Specialty Advisers are practicing clinicians from across England who work part-time at NHS England, providing clinical leadership, advice, input and support across distinct areas of NHS conditions and services ranging from cancer and cardiovascular disease to urgent and emergency care and major trauma in line with the NHS Long Term Plan.
Current national clinical directors and specialty advisers
- Alcohol dependence
- Antimicrobial resistance and infection prevention and control
- Blood and infection programme of care
- Blood and marrow transplantation
- Breast screening
- Cancer surgery
- Cardiovascular disease prevention
- Children and young people
- Children and young people’s cancer
- Congenital heart services
- Diabetes and obesity
- Eating disorders
- Elective Care
- End of life care
- Eye care
- Flu and routine vaccinations
- Gender dysphoria
- Health and justice
- Heart disease
- Hepatobiliary and pancreas
- Internal medicine
- Learning disabilities and autism
- Long COVID
- Major trauma and burns
- Maternity and women’s health
- Medicines optimisation
- Mental health
- Mental health pharmacy
- Metabolic disorders
- Neonatal critical care
- Neurosurgery and spinal surgery
- Nuclear medicine
- Older people and integrated person-centred care
- Paediatric critical care
- Paediatric neurosciences
- Perinatal mental health
- Peri-operative care
- Physiological measurements
- Proton beam therapy
- Public health screening
- Rehabilitation, disability and spinal cord injury
- Renal services
- Secure mental health
- Specialised blood disorders
- Specialised immunology and allergy
- Specialised paediatric renal services
- Specialised rheumatology
- Specialised surgery in children
- Tobacco addiction
- Urgent and emergency care
- Vascular disease
- Violence reduction
National specialty adviser for alcohol dependence
Professor Julia Sinclair is Professor of addiction psychiatry and leads the alcohol care team at University Hospital Southampton. Her priority is to improve outcomes for patients with alcohol use disorders (AUD) and co-morbid physical and mental health conditions by research, teaching, policy, and clinical practice. Her clinical roles include developing an integrated alcohol strategy across local services, offering direct clinical care, and work with Regulatory Bodies including the GMC. Her primary research aim is to conduct clinically relevant research into the harms of alcohol use, specifically the impact on clinical outcomes in terms of prevention, engagement and response to treatment. She also has a long track record of teaching and training health professionals and is Chair of the Addictions Faculty of the Royal College of Psychiatrists.
National clinical director for antimicrobial resistance and infection prevention and control
Professor Matt Inada-Kim is consultant in Acute Medicine at Hampshire Hospitals, National Clinical Director for Infection management, Antimicrobial Resistance and Deterioration, National Clinical Lead for COVID oximetry@home/virtual wards, Chair of the COVID pathways group at NHS England and Clinical Director for digital innovation at Wessex AHSN.
To this end he has developed and lead on the oximetry at home and virtual ward models, and the COVID management guidance/policy in all settings and evidence for the role of oximetry for all patient groups. This is now endorsed by the World Health Organization and has been disseminated internationally.
He has worked to improve processes in the recognition, escalation, communication and response to the deteriorating patient. To this end, he has worked to standardise the country to using NEWS2 as a single language of sickness and communication between healthcare professionals across the whole patient pathway.
He is also improving the measurement and definitions of sepsis and infection to assist epidemiology, research and policy; and developed the suspicion of sepsis infection coding set that is used to determine the infection and sepsis burden across England.
He is developing a unified national strategy around infections management to encompass clinical care, prevention, diagnostics, training, treatment, antimicrobial resistance and measurement.
He is working across the country to develop interoperable digital systems and databases that will enable machine learning and AI systems at scale alongside existing clinical pathways.
National clinical director for antimicrobial resistance and infection prevention and control
Professor Mark Wilcox has formerly been the Director of Infection Prevention (4 years), Infection Control Doctor (8 years), Clinical Director of Pathology (6 years) and Head of Microbiology (15 years) at LTHT.
Since the pandemic, Professor Wilcox has been a member of UK Scientific Advisory Group on Emergencies (SAGE, COVID-19; and chairs one of its subgroups on Nosocomial Infection). He is co-chair of DHSC’s UK Technical Validation Group for COVID-19 tests, and is the clinical lead for winter virus multiplexing. He is a member of the Scientific Advisory Board for the EU Innovative Medicines Initiative’s COMBACTE-NET consortium. From 2017, he was seconded one day per week to NHS Improvement to support the delivery of the new national target to reduce healthcare associated Gram-negative blood stream infections in England. He was the Deputy Chair of the UK Department of Health’s Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) Committee up until 2018; he became an invited expert/observer to this committee from 2021.
He is an expert advisor to the Department of Health in England on healthcare associated infections (HCAIs), UK NICE (C. difficile management and antimicrobial evaluations project), the UK EPIC/NICE projects, the Health Technology Assessment (HTA) programme on Healthcare Associated Infection, the Wellcome Trust and CARB-X panel on novel antimicrobials, the Centre for Health Economics (University of York) for the (UK NICE) evaluation of the value of antibiotics to the NHS, and the European Centre for Disease Control. He is a member of UK, European and US working groups on C. difficile infection, and is on the Editorial Boards of Clinical Infectious Diseases, Journal of Hospital Infection and Infectious Diseases in Clinical Practice. He has provided clinical advice as part of the FDA/EMA submissions for the approval of several novel antimicrobial agents, 1998-2022.
Professor Wilcox heads a Healthcare Associated Infection research team at the University of Leeds, comprising ~30 doctors, scientists and nurses; projects include multiple aspects of Clostridium difficile infection, diagnostics, antibiotic resistance and the gut microbiome, staphylococcal infection, and the clinical development of new antimicrobial agents. He has a track record of translational research, including providing the basis of clinical advice to the NHS. He has been the Principal/UK Investigator for 15 clinical trials of new anti-infective drugs, 1999-2021, has carried out multiple NIHR portfolio studies on healthcare associated infection topics. He has authored >560 papers and published a number of books and chapters. He is co-editor of Antimicrobial Chemotherapy (5th/6th/7th Eds, 2007/12/15).
National specialty adviser for autism
Dr Amy Dissanayake is a GP at Adur Health Partnership in Shoreham-by-Sea, having obtained her medical degree and BSc in Leeds and started her GP training in Norfolk.
As well as previously working in quality and clinical effectiveness clinical lead roles, Amy is Medical Director for NHS Sussex Integrated Care Board. This has involved supporting the transforming care agenda, introduction of the Learning Disability Mortality Review (LeDeR), and jointly developing a quality kite mark for primary care for people with a learning disability. She is now Medical Director for West Sussex Clinical Commissioning Group (soon to be NHS Sussex) and looks forward to bringing these system leadership skills to the role of National Specialty Advisor for Autism.
In addition, Amy is the E-media Editor for the Royal College of General Practitioners journal, InnovAiT, writing a regular blog and social media for trainee GPs and their trainers.
Dr Janine Robinson is a Consultant Clinical Psychologist and a specialist in the field of autism in adults. She completed her D.Clin.Psy. at the Institute of Psychiatry, King’s College, London in 2000. She holds a part-time consultant role in an adult autism diagnostic assessment clinic and is National Specialty Adviser for autism with NHS England supporting the NHS Long-term Plan and the priorities identified for autism. Janine has a long history in health education (Scotland) where, with colleagues and through wider consultation she played a key role in developing a competency framework for autism, commissioning autism education and training across the workforce with an emphasis on building autism capacity across mainstream services.
Janine contributes to clinical research, training and supervision in autism with the goal of improving identification, diagnosis and autistic individuals’ experiences of the NHS and wider public services. She is currently the local (Cambridgeshire) PI of a national NIHR-funded research project (UCL) seeking to improve diagnostic assessments of adults and is working closely with Professor Julia Sinclair (National Specialty Adviser for alcohol dependence) on identifying priorities for research and policy in Substance use, Alcohol and Behavioural addictions in Autism (SABAA) as part of a Priority Setting Partnership.
National specialty adviser for blood and infection programme of care
Dr Siraj Misbah is Lead Consultant in Clinical Immunology at Oxford University Hospitals Trust and Honorary Senior Clinical Lecturer in Immunology at Oxford University. He has particular interests in immunodeficiency, autoimmune disease, complex drug allergy and immune-mediated therapeutics, reflected in membership of the Commission on Human Medicines and as Chair of the Clinical Trials, Biologics and Vaccines Expert Advisory Group at the MHRA (2012-22). During the pandemic, he chaired the MHRA COVID-19 vaccine safety surveillance expert advisory group in 2020 and has since continued as a member of the COVID-19 therapeutics and vaccine benefit-risk expert advisory groups.
Siraj has been a member of Scientific Advisory Groups at the European Medicines Agency. He was elected President of the Union of European Medical Specialists Section of Laboratory Medicine (2016-2022). He has previously held a number of leadership positions at NHS England and is a member of the Department of Health and Social Care’s Independent Advisory Group, which defined the disease cohorts at ‘highest risk’ from COVID-19.
National specialty adviser for blood and marrow transplantation
Dr Fiona Dignan has been a consultant in haemato-oncology and stem cell transplantation at Manchester University NHS Foundation Trust since 2012. She was appointed as clinical lead for haematology at Manchester Royal Infirmary in 2014. Her main clinical interests are acute leukaemia, chronic myeloid leukaemia and allogeneic transplantation. She is the lead author of national clinical practice guidelines on post-transplant complications including graft-versus host disease, veno-occlusive disease and respiratory viral infections.
She is Secretary for the British Society for Blood and Marrow Transplantation and Cellular Therapy. She has also chaired the Anthony Nolan expert steering group on post-transplant care and co-chaired the Delivering for Patients Working Group of the UK stem cell forum. She has been a member of the Clinical Reference Group (CRG) for Blood and Marrow Transplantation since 2016 and was appointed Chair of the CRG in 2020. During her period as Chair, she contributed to the NICE rapid guidance for BMT services during the COVID-19 pandemic.
National specialty adviser for breast screening
Dr Louise Wilkinson is a Consultant Breast Radiologist at the Oxford Breast Imaging Centre. She was a Director of Screening for many years in London. She chaired the PHE chaired the Advisory Committee on Breast Cancer Screening and is Professional Clinical Advisor to Screening Quality Assurance Service in London. She is a member of the Breast Screening Radiology Clinical Professional Group and subject matter expert for Digital Transformation of Screening.
National clinical director for cancer
Professor Peter Johnson is Professor of Medical Oncology at the University of Southampton. He was Chief Clinician for Cancer Research UK for ten years where he established pilot work in genomic analysis for cancer patients. He co-chaired the CRUK/Royal College of GPs Cancer Clinical Priority Group. He is currently Chair of the Royal College of Physicians/Association of Cancer Physicians joint specialty committee on medical oncology. He was appointed CBE for services to cancer research in 2016.
National clinical adviser on cancer innovations
Dr Lennard YW Lee is Associate Professor at the University of Oxford and senior clinical research fellow at the University of Birmingham.
He is a Medical Oncologist at Oxford University Hospitals NHS Foundation Trust.
He works at the NHS England Cancer Programme as clinical adviser for cancer innovations and diagnostics.
National specialty adviser for cancer surgery
Mr Alistair Simpson is a Consultant Colorectal and General Surgeon. He is an Honorary Associate Professor at the University of Nottingham and the Clinical Director of the East Midlands Cancer Alliance.
He is the lead robotic surgeon at Nottingham University Hospitals and the lead surgeon for advanced colorectal cancer, specialising in complex surgery for patients suffering from sarcoma.
He took up his role as East Midlands Cancer Alliance Clinical Director for cancer during the pandemic and is responsible for leading innovations in cancer care and improving outcomes for patients. During this time he led a team which won the 2022 National Patient Experience Award (PENNA) for improving Colorectal cancer Care in the East Midlands. He also established and chairs the East Midlands Genomics Expert Clinical Advisory Group.
National clinical director for cardiovascular disease prevention
Dr Shahed Ahmad is a public health doctor who is currently working as the Medical Director for System Improvement and Professional Standards for the South East region of NHS England and Improvement. In this role he is leading work by the strategic clinical networks to improve patient outcomes. He is a member of the national Cardiovascular Disease System Leadership Group and the CVD, stroke and respiratory Delivery Boards. He has previously been a Director of Public Health leading work in Enfield and across London to improve the management of people with hypertension and reduce the deprivation gap in life expectancy.
National specialty adviser for cardiovascular disease prevention
Helen Williams has worked as a CVD specialist pharmacist for the past 25 years in hospital, community and primary care settings. She has spearheaded a wide range of activities across South London and beyond to improve the care of patients with or at risk of cardiovascular disease (CVD). She leads on the development and implementation of consensus evidence-based guidance for use across South London’s 12 CCGs and 7 acute trusts, covering a population of 3.6million and supporting local practitioners through education and training, guideline implementation, clinical audit, service development and provision of virtual or face to face clinics. For the past three years she has provided clinical advice to inform the delivery of local and national AF AHSN programmes to optimise the detection and management of AF with the aim of reducing AF-related stroke. She developed the pharmacist-led virtual clinic model to optimise uptake of anticoagulation in AF in Lambeth and Southwark CCGs, which is now being spreads nationally through the NHSE AF demonstrator programme. Helen has supported the commissioning and delivery of CVD new models of care to address the CVD ABCs, – AF, blood pressure and cholesterol.
National specialty adviser for chemotherapy
Dr Anne Rigg is a Consultant Medical Oncologist specialising in the treatment of Breast Cancer at Guys and St Thomas Hospital in London. Dr Rigg trained at the Royal Marsden Hospital and completed a PhD at Imperial College in Molecular Genetics and Gene Therapy for cancer. Dr Rigg is Clinical Director of Oncology at Guys and St Thomas overseeing care for cancer patients across South East London. She is an expert member of the NICE Patient Access Scheme Liaison Unit and has advised on several governmental groups relating to cancer.
National clinical director for children and young people
Professor Simon Kenny is a consultant paediatric surgeon at Alder Hey Children’s NHS Foundation Trust in Liverpool where he led the introduction of minimally invasive paediatric surgery. He is also the national clinical lead for paediatric surgery for the Getting It Right First Time programme and a senior clinical advisor for the National Consultant Information Programme (NCIP). He was previously clinical director for surgery in his Trust. His research interest is in regenerative medicine and in the use of technology.
Joint national specialty advisors for children and young people
Dr Matthew Clark is a paediatric consultant and specialty lead at East Sussex Healthcare NHS Trust. He was previously on the governing body of NHS Camden Clinical Commissioning Group and clinical lead of admission avoidance in the North Central London Sustainability and Transformation Partnership/Integrated Care System. Matthew studied medicine at Cambridge University, completed his paediatric specialists training in London and co-founded The Welbodi Partnership, supporting healthcare in Sierra Leone. Matthew has extensive experience in service redesign and transformation working across community, primary and secondary care.
National specialty adviser for children and young people’s cancer
Dr Julia Chisholm undertook specialist training in paediatric oncology at The Royal Marsden and Great Ormond Street Hospitals. She was appointed as a full time NHS Consultant Paediatric Oncologist at Great Ormond Street Hospital in 1999 and in 2010 moved to The Royal Marsden, specialising in the management of children and young people with soft tissue sarcoma and melanoma. She chaired the National Cancer Research Institute Children’s Group from April 2019- December 2022 and was appointed Reader in Young People’s Sarcoma Clinical Trials at the Institute of Cancer Research in 2022.
Dr Chisholm led development of the new Teenage and Young Adult service at The Royal Marsden following her appointment in 2010. She was Head of its Children and Young People’s Unit from 2012-2018, co-Chair of the South Thames Children’s Cancer Network from 2012-21, Acting Clinical Director for the South Thames Children and Young People’s Cancer Operational Delivery Network (ODN) from 2021-22 and is currently the ODN’s Paediatric Transformation Lead. She also served as the medical Trustee for the charity Young Lives versus Cancer from 2014-2022.
National specialty adviser for congenital heart services
Mr Rafael Guerrero is an international leader in Paediatric and Adult Congenital Cardiac Surgery, he is the Chief of Congenital Cardiac Surgery and Director of the Heart Centre at Alder Hey Children’s Hospital.
Mr Guerrero is an Honorary Associate Professor at the University of Liverpool and Honorary Visiting Professor at Qingdao Women and Children Hospital (QWCH), China.
Internationally, Mr Guerrero has developed the first UK NHS partnership with a Children Hospital in China (QWCH-Qingdao) and the Children Heart Link USA, leading annual multidisciplinary medical missions.
Mr Guerrero served as the Chair of the Congenital Committee and board member of the Society of Cardiothoracic Surgeons of Great Britain and Ireland 2018-2022.
He developed the North of England Training Programme in Congenital Heart Surgery, one of only two accredited UK programmes and he has trained many successful surgeons from around the world.
During the pandemic, he led the CHD surgery NHS national response and co-developed the NHS National Operation Level Escalation Plan and surgical prioritisation.
National clinical director for dementia
Dr Alistair Burns is a consultant old age psychiatrist, Greater Manchester Mental Health NHS Foundation Trust. He was made an honorary fellow of the Royal College of Psychiatrists in 2016, received the lifetime achievement award from their old age Faculty in 2015 and was awarded the CBE in 2016 for contributions to health and social care, in particular dementia.
National clinical director for diabetes and obesity
Professor Jonathan Valabhji is a consultant diabetologist at Imperial College Healthcare Trust where he has built up a multi professional service demonstrating high quality outcomes for patients with diabetes. His research interests include diabetes epidemiology and population health and diabetic foot disease.
In the role of National Clinical Director, he has provided clinical leadership to the national Diabetes Programme over the last seven years in collaborative work between NHS England, Public Health England and Diabetes UK., and through the Long Term Plan has established the NHS England Obesity Programme.
He was awarded an OBE for services to diabetes and obesity care in 2019.
National specialty advisor for diabetes and obesity
Dr Partha Kar is a consultant diabetologist at Portsmouth Hospitals NHS Trust where he has shifted a significant proportion of the care of patients with diabetes from hospital to community-based care with excellent outcomes. He has been an associate National Clinical Director for Diabetes for the past three years where he has focussed on the use of technology to support better patient care. He is also working with Diabetes UK to improve the health of patients with diabetes and mental health disorders. Dr Kar is also the co-lead for diabetes for the Getting It Right First Time programme.
National specialty adviser for eating disorders – all ages
Dr Dasha Nicholls is Reader in Child Psychiatry in the Division of Psychiatry at Imperial College London, Honorary Consultant Child and Adolescent Psychiatrist in the Children and Young People’s (CYP) Eating Disorders Service in Central and Northwest London NHS Foundation Trust, and Clinical and Strategic Director for National Audits and Research at the Royal College of Psychiatrists (RCPsych). Until moving to Imperial in 2018, Dr Nicholls co-led the Feeding and Eating Disorders service at Great Ormond Street Hospital. She is past-President of the Academy for Eating Disorders and was Chair of the RCPsych Eating Disorders Faculty (2015-19).
- Her research focuses on CYP with feeding and eating disorders and those living at higher weight, as well as CYP population mental health, in particular risk factors and early intervention. She served on the NICE eating disorders guideline committee, the NICE quality standards committee, the NHS England Expert Reference Group for eating disorders commissioning guidance and the CYP obesity oversight group. She co-led the National Whole Team training for CYP EDS and chaired development of the Medical Emergencies in Eating Disorders guidance (2022). She is a member of the BEAT clinical advisory group.
Return to top
Joint national clinical directors for elective care
Ian Eardley is a Consultant Urological Surgeon in Leeds where he has worked since 1993, specialising in andrology, reconstruction of the urinary tract and genital surgery. He was Vice President of the Royal College of Surgeons of England until July 2018 and he has held a number of national posts relating to surgical training including the role of Chair of the Joint Committee for Surgical Training. He is the current Chair of Council of the Medical Protection Society. In 2014 the British Association of Urological Surgeons awarded him the St Peter’s medal for his contributions to Urology.
Stella Vig has more than 30 years’ experience in the NHS and was appointed as a consultant in vascular and general surgery at Croydon University Hospital in 2006. Her specialist interests are vascular and general surgery. She is also the Clinical Director of Elective Recovery at Croydon Health Services NHS Trust, which opened a ‘hospital within a hospital’ to safely continue planned care and surgery during the pandemic. Across London, Stella is also the Regional Clinical Director for General Surgery for the ‘High Volume, Low Complexity’ and ‘Get It Right First Time’ best practice programmes.
With a focus on patient care, developing trainees and supporting colleagues, she has taken leading roles in clinical education, as well as service transformation. These include chairing the JSCT core surgery advisory committee to the four Royal Colleges, and the London Diabetic Foot Network, which brings healthcare professionals together, and has reduced amputation rates across London.
She was elected as a member of the Royal College of Surgeons of England Council in 2016.
National clinical director for end of life care
Professor Bee Wee is a consultant in palliative medicine and clinical lead for the palliative care service at Oxford University Hospitals NHS Foundation Trust. She is a Governing Body Fellow of Harris Manchester College, Oxford University. She has been National Clinical Director for Palliative and End of Life Care since 2013. During this time, she led the establishment of a national end of life care programme, the Leadership Alliance for Care of the Dying and now co-chairs the National Ambitions Partnership for Palliative and End of Life Care. Her priority is to enable consistently high-quality palliative and end of life care for everybody who needs it, wherever they are and whatever their circumstances. She holds a Founding Senior Fellowship of the Faculty of Medical Leadership and Management, an Honorary Doctorate of Science at Oxford Brookes University and was awarded a CBE for services to palliative and end of life care in 2020.
National specialty adviser for endoscopy and screening
Dr Robert Logan is a Consultant Gastroenterologist at Kings College Hospital with a research and specialist interest in non-invasive diagnostics for more than 30 years. He has been a longstanding member of the British Society of Gastroenterology, including being elected to Council and serving as a Trustee. In 2010 he co-authored the BSG Commissioning Guidance for GI and Liver disease, which included ‘Interface services’ as a forerunner of integrated care. Until recently he was the RCP Regional Adviser for South London where he also held positions as Deputy Chair of GI commissioning for Lambeth and Southwark CCGs. In 2018 he became the NSA for Endoscopy at NHS-E and has subsequently been involved in the introduction of FIT testing for both the National Bowel Cancer Screening Programme and the symptomatic service.
National clinical director for eye care
Louisa Wickham was appointed a Consultant at Moorfields in 2009. She is a Vitreoretinal Surgeon with a particular interest in the management of diabetic retinopathy, retinal detachment and lens dislocation surgery. She has a research degree in the surgical management of retinal detachment and post-operative scarring.
Louisa developed an interest in clinical leadership and management as a trainee, leading her to complete an MSc in health services management at London University. She went on to develop her skills further as a Leadership Fellow for the Health Foundation and as a European Leadership Fellow at INSEAD. She has held a number of leadership roles in the NHS and works with the Royal College of Ophthalmologists and Royal Society of Medicine to promote clinical leadership for doctors at all stages of their training.
Louisa is an advocate of surgical transformation and innovation. She was appointed Chief Surgeon at Moorfields Eye Hospital in 2019 and during this time oversaw the trust’s response to the COVID-19 pandemic and initial recovery including COVID-19 surgical pathways and the Moorfields cataract drive. Louisa was appointed Medical Director of Moorfields in 2020.
National Specialty Advisor for flu and routine vaccinations
Dr Rebecca Cordery is a Consultant Epidemiologist with the Immunisation and Vaccine Preventable Diseases Division in UKHSA and has worked as a Consultant in Communicable Disease Control with the London Health Protection Teams (UKHSA) for over 10 years. The Health Protection Teams are responsible for managing notifications of infectious diseases, lead the management of outbreaks of infection, and support the multi-agency response to incidents involving non-infectious environmental hazards.
Rebecca has a particular interest in vaccination and is the London region vaccine preventable diseases and immunisation lead for UKHSA and a member of the London Immunisation Board. Rebecca is also currently a member of the UK Joint Committee on Vaccinations and Immunisation (JCVI), appointed in 2019.
National specialty adviser for gender dysphoria
Dr Derek Glidden is a Transgender Healthcare Consultant (Psychiatrist), at the Nottingham Centre for Transgender Centre for Transgender Health Network (NCTHnet) at Nottinghamshire Healthcare NHS Foundation Trust. He was appointed as Clinical Lead for NCTH in 2020 and later Clinical Director of NCTHnet in 2021.
He is an Honorary Assistant Professor at University of Nottingham, School of Medicine. He provides assessment and treatment for gender affirming medical interventions and assessments and recommendations for gender affirming surgeries. In addition to his work in Transgender Healthcare, he is a specialist in Autism Spectrum Conditions (ASC) and neurodiversity. He has a particular clinical and academic interest in the co-occurrence of ASC and neurodiversity in those seeking transgender healthcare. He has published on this topic and presented (inter)nationally.
Pronouns: He, Him, His
National specialty adviser for gynaecology
Professor Janice Rymer obtained her medical degree at Auckland University and did her specialist training in Obstetrics and Gynaecology in New Zealand and the UK. She is Dean for Student Affairs and Professor of O&G at King’s College London, and Consultant Gynaecologist at Guy’s and St Thomas’s NHS Foundation Trust. From 2016 to 2019, she was Vice President of the RCOG, having served on RCOG council for 12 years. From 2010 to 2013, she was Dean of Undergraduate Medicine at KCL. She was a Council member of the British Menopause Society from 1997-2002 and 2009-2015, and is a member of the British Society for Gynaecological Endoscopy. She has been a GMC assessor for medical schools since 2006. Her areas of expertise include minimal access surgery, endometriosis, ovarian failure, female genital mutilation and medical education. She has published over 140 peer-reviewed papers and 16 textbooks.
National specialty adviser for haemoglobinopathies
Dr Subarna Chakravorty is a Paediatric Haematologist with a special interest in non-malignant haematology and stem cell transplant for haemoglobinopathy and non-malignant diseases. She joined King’s College Hospital as consultant in July 2015. Prior to that, Subarna led the Paediatric Haemoglobinopathy service at Imperial College Healthcare NHS Trust and the Imperial Paediatric Red Cell Disorders Network for 5 years, where she was also involved in the bone marrow transplant programme for paediatric haemoglobinopathy. Since 2021, Subarna has been involved in the adult sickle cell bone marrow transplant service at King’s College Hospital.
Subarna was the national lead for the UK Haemoglobinopathy Peer Reviews, 2018-2020. She is one of the clinical leads at the Southeast London and Southeast England Region Haemoglobinopathy Coordinating Centre for Sickle Cell disease. She is a trustee of the British Society for Haematology and the UK Forum on Haemoglobin Disorders.
National clinical director for health and justice
Dr Sunil Lad is a Consultant Counselling Psychologist at Northamptonshire Healthcare Foundation Trust. Working in prisons since 2003, he has developed a special interest in justice settings and the link between healthcare outcomes and reducing reoffending. As part of the NHS long term plan he is the Clinical Lead for the Enhanced Reconnect programme, which supports people leaving prison with complex health needs who are at high risk of reoffending to get tailored treatment for mental health, substance misuse and other services, for up to a year after release.
He has given clinical leadership in a variety of healthcare services in justice settings including a high secure prison, immigration removal centre, young offender institutions and Mental Health Treatment Requirements in the community which are being rolled out across the country with good outcomes.
Sunil also holds a Masters in Forensic Psychology which informs his knowledge in understanding offending behaviour.
National clinical director for heart disease
Professor Nick Linker is a consultant cardiologist at the James Cook University Hospital in Middlesbrough. He has been honorary Secretary of the British Cardiovascular Society, Secretary then President of the British Heart Rhythm Society, and has been a member of the cardiac services specialised commissioning clinical reference group for seven years. He has led work on Specialised services for heart rhythm disturbances and approaches to implement more integrated care for patients with rhythm disturbances, interfacing with the Getting It Right First Time programme and with NICE. He is also working with the Clinical Director for the personalised care programme to develop a shared decision-making tool and PROMs for people with atrial fibrillation.
National specialty advisor for heart disease
Dr Dawn Adamson is an interventional cardiologist and Associate Medical Director at the University Hospital of Coventry and Warwickshire (UHCW). She developed a specialist interest in obstetric cardiology and wrote the Oxford Handbook of Heart Disease in Pregnancy. She was involved in setting up and is now President of the UK Maternal Cardiology Society, an affiliate of the British Cardiovascular Society (BCS). She runs a regional obstetric cardiology service and is also clinical lead for the Acute Congenital Heart Disease service at UHCW. Dawn is currently on the expert advisory group for out-of-hospital cardiac arrest (OOHCA) for NHS England, on the arrest trial steering committee and in 2021 became the cardiac pathways improvement programme, East and West Midlands lead for OOHCA. She sits on the council of the British Cardiovascular Society and is also currently the secretary of the West Midlands Physicians Association.
National specialty adviser for Hepatobiliary and pancreas
Dr Richard Aspinall is a Consultant Hepatologist in Portsmouth where he leads the services for people with liver conditions. He has particular expertise in service development, quality improvement and clinical research. He established the Portsmouth Liver Centre which has since become one of the largest hepatology services in the South of England. He is also the national Industry Lead for the NIHR hepatology research network and has built a thriving clinical trial programme. He has been a steering group member for the national Improving Quality in Liver Services (IQILS) accreditation programme since its inception.
Richard qualified as a doctor in 1992 and undertook postgraduate training in hospitals in Liverpool, Sheffield, Cambridge and London. He has a research PhD in Immunology from Imperial College London. He was an Associate Hepatologist at Scripps Clinic in San Diego and a Consultant at the University Hospital of Wales in Cardiff before relocating to Portsmouth in 2010. Richard’s clinical interests include complications of cirrhosis, alcohol-related illness, liver cancers and autoimmune liver diseases.
National specialty adviser for HIV
Dr Laura Waters is a Consultant Physician in Sexual Health & HIV and leads the HIV service for Central & North West London NHS Trust. She is the immediate past Chair of the British HIV Association (BHIVA) and has been an HIV CRG member and co-chair of its drugs sub-group since 2016. She helped to implement and analyse a national cost-saving programme and was part of the clinical team that oversaw the move from regional to national HIV drugs procurement and the development of a national prescribing toolkit. She is a previous trustee of the British Association for Sexual Health & HIV (BASHH).
Laura has led or co-authored several national guidelines including the BHIVA treatment guidelines for adults living with HIV-1, the BHIVA/BASHH/British Infection Association HIV testing guidelines and the BHIVA/BASHH HIV post-exposure prophylaxis guidelines. She led the development of rapid guidance on COVID-19 management, COVID-19 vaccines and monkeypox prevention & treatment for people with HIV.
National specialty adviser for imaging
Professor Sam Hare (@lungdiagnosis) is a consultant cardiothoracic radiologist at the Royal Free London NHS Foundation Trust. As an executive committee member of the British Society of Thoracic Imaging, Sam was central in implementing national COVID-19 imaging protocols and co-authoring national reporting guidelines for lung cancer screening. Sam is passionate about service transformation and the use of artificial intelligence in optimising diagnostic imaging workflows.
After undertaking a thoracic radiology fellowship in North America (2009-2010), Sam was appointed as consultant thoracic radiologist at The Ottawa Hospital in Canada, specialising in lung cancer screening & early diagnosis. He returned to the NHS in 2011 and pioneered the innovative ambulatory lung biopsy service at the RFL NHS Trust. The service has been recognised with several national awards: NHS Innovation Challenge Prize for Cancer Care; BMJ Award for Cancer Team of the Year; HSJ Acute Sector Innovation.
National clinical director for internal medicine
Dr Richard Fluck is a Consultant Nephrologist at University Hospitals Derby and Burton NHS Foundation Trust. He has previously been Chair of the Think Kidneys Programme Board and Co-Chair of the Transforming Participation in Chronic Kidney Disease Programme.
Richard trained at Trinity Hall, Cambridge and the London Hospital Medical Collegebefore he moved into research at St Bartholomew’s Hospital. Richard was appointed a British Heart Foundation Fellow to explore the link between cardiovascular disease, calcium signalling and abnormalities of calcium metabolism in chronic kidney disease. He returned to the Royal London Hospital as lecturer and honorary senior registrar in nephrology, before being appointed as a single handed nephrologist at Derby in 1996.
In 2013 Richard was appointed National Clinical Director for Renal for a three year tenure and has also chaired the Kidney Alliance as well as being President of the British Renal Society. He chairs the national Home Dialysis Improvement initiative as part of the Kidney Quality Improvement Partnership.
Interim national clinical director for learning disabilities and autism
Anne Worrall-Davies has worked for 30 years in Children and Young People’s Mental Health as a Consultant Psychiatrist in community, early intervention in psychosis, inpatient and outreach settings. She joined NHS England’s Learning Disability and Autism Programme in 2021, and as Senior Psychiatrist Lead (Children and Young People) brought a clinical perspective and leadership to support the delivery of the NHS Long Term Plan priorities for autistic people and those with a learning disability.
She has six years’ experience of being a non-executive director in the not-for-profit and social housing sector, and currently sits on the board of Future Directions Community Interest Company. Anne continues to have an interest in innovative and person-centred ‘alternative to hospital’ models of delivering care at the specialist end of the pathway for autistic people and those with a learning disability. She also particularly enjoys working across the wider health, education and social care system.
She is passionate about co-production: being a parent to a young autistic adult with a learning disability and epilepsy helps ensure that she always keeps the voice of lived experience at the centre of her work.
Joint national specialty advisers for long COVID
Dr Melissa Heightman is a respiratory physician with an interest in in integrated respiratory services and interstitial lung disease. She qualified from the University of Cambridge in 2000 and trained in respiratory medicine at the Brompton Hospital and in North London. She held a Wellcome Trust Clinical Training Fellowship from 2007 to 2011.
She has an interest in transformation of outpatient services and in developing new models of care for long term conditions across the integrated care system. She is a member of the clinical leadership group of the London Respiratory Clinical Network which has developed guidance for London in meeting respiratory priorities in the NHS long term plan and relating to the COVID19 pandemic.
Dr Heightman is clinical lead for the Post COVID clinic at UCLH and is consultant lead for the multi-professional Post COVID network in North Central London. She is a member of the NHSE task force considering COVID follow up service development and was previously an expert adviser to NICE re guideline development for management of the long-term effects of COVID19. She is clinical lead for the NIHR funded STIMULATE-ICP research program evaluating care pathways and treatments in Long COVID.
National specialty adviser for major trauma and burns
Dr Anne Weaver was appointed as a Consultant in Emergency Medicine & Pre-Hospital Care at the Royal London Hospital in 2004. She is an active clinician in both Emergency Medicine & Pre-hospital medicine. She was appointed as Lead Clinician for Pre-Hospital Care at HEMS (London’s Air Ambulance) from 2007-14. and has been the Clinical Director for Trauma at the Royal London Major Trauma Centre since 2016.
Anne has contributed to the development of national and international guidance for Pre-Hospital Care and Major Trauma through her work with NICE (2016), the Faculty of Pre-Hospital Care (RCSEd) Clinical Advisory Board, DoH working groups, the European HEMS and Air Rescue Committee (EHAC) Medical Working Group and the Royal College of Emergency Medicine.
Anne served as a Trustee for London’s Air Ambulance (2007-14) and became a Trustee for the Royal College of Emergency Medicine in 2021.
National clinical director for maternity and women’s health
Dr Matthew Jolly is a consultant obstetrician and gynaecologist at Western Sussex Hospitals NHS Trust where he has previously been a Clinical Director. He has also been Clinical Director of the Sussex Maternity and Neonatal Network and Joint Clinical Director of the South East Coast Maternity, Children and Young People strategic clinical network. He has been the NCD for Maternity and Women’s Health for the past three years, contributing to the development of the Maternity and Neonatal Health Safety Collaborative an working with NHS Resolution and DHSC to refresh the Clinical Negligence Scheme for Trusts.
National specialty adviser for medicines optimisation
Charlotte Skitterall was appointed to the role of Group Chief Pharmacist for Manchester University NHS Foundation Trust, a group of ten hospitals and community services in October 2018. Prior to that she has was Chief pharmacist and Head of Medicines Management for Trafford Health Economy and more latterly Chief Pharmacist at the University Hospitals of South Manchester.
Charlotte is currently Chair of the Greater Manchester Medicines Management Group and nationally she supported key workstreams in relation to the implementation of the COVID-19 vaccine.
She has close working relationships with the University of Manchester, overseeing the pharmaceutical support to the Clinical Trials Unit and a member of the Advisory Board for the Division of Pharmacy. In August 2021, she was awarded a MAHSC Honorary Clinical Chair in the Faculty of Biology, Medicine and Health at the University of Manchester.
National clinical director for mental health
Professor Tim Kendall was appointed NCD for Mental Health in April 2016. He chairs a number of committees to implement the national mental health strategies and leads programmes around impact of COVID, suicide reduction, talking therapies and digitalisation. He chaired the steering group and hosted the inaugural Global Ministerial Summit on Mental Health, in October 2018.
Tim has published widely, awarded the 2004 Lancet Paper of the Year and is visiting Professor at UCL since 2009. He has been invited to consult to a diverse range of foreign governments. Tim is also Director of National Collaborating Centre at Royal College of Psychiatrists and UCL since 2001, where he chaired the first ever NICE guideline – on schizophrenia. He has facilitated the production of 30 or more NICE guidelines since. He works as consultant psychiatrist for the homeless in Sheffield. He is a strong advocate for inclusion of service users, having convened the first NICE Expert Reference Group which included members with lived experience.
National specialty advisor specialised commissioning (mental health)
Dr Daniel Dalton is a forensic psychiatrist and medical director at Norfolk & Suffolk Foundation NHS Trust. He has worked in secure and community forensic services with a special interest in autism and learning disability. He has been a member of the Clinical Reference Groups for Secure mental health between 2013 and 2018 and has been National Specialty Advisor for Specialist Mental Health since 2018. Dan has supported programmes that put quality and patient involvement at the heart of commissioning and service development, that seek to tackle inequality and reduce restrictive practices, and that empower people who use services so they can receive their care close to home in the communities where they live, including the Recovery and Outcomes programme for secure services, and the development of Building the Right Support, the model for best practice in developing services for people with a learning disability and autism.
National specialty advisor for adult mental health
Dr Mike Hunter trained first in medicine and then in psychiatry and is now Executive Medical Director at Sheffield Health and Social Care NHS Foundation Trust. His board-level responsibilities include quality improvement, clinical effectiveness, research and development, clinical data protection, and medical leadership and education.
He has been National Specialty Advisor for Adult Mental Health and Chair of the Specialised Commissioning Specialised Mental Health Services Clinical Reference Group (CRG) since 2017. The CRG’s work covers adult eating disorders, tier 4 personality disorder, deaf mental health services and nationally commissioned obsessive–compulsive disorder and body dysmorphic disorder services. He works clinically as a Consultant Psychiatrist in a single point of access for secondary care.
National clinical director for children and young people’s mental health
Dr Prathiba Chitsabesan is a Consultant in Child and Adolescent Psychiatry working in a large mental health and learning disability trust (Pennine Care NHS Foundation Trust). Lead consultant in 2005, she became Clinical Director in 2015 and subsequently Associate National Clinical Director in 2017 (NHS England Children and Young People’s Policy Team). She has an interest in the needs of children and young people in contact with the criminal justice system. Over the last 15 years she has contributed to a number of national reports and guidance for NHS England, Public Health England, the Office of the Children’s Commissioner and the Youth Justice Board. She continues to be research active as a Visiting Professor (University College London and Manchester Metropolitan University) and has contributed to the development and delivery of a number of regional (Greater Manchester) and national transformation programmes.
National specialty adviser for mental health pharmacy
Peter Pratt has worked as a Specialist Pharmacist in Psychiatry for the past 40 years. Prior to his appointment as National Clinical Director for Mental Health Pharmacy, he has held a number of appointments with NHS England as the Head of Medicines Strategy in Mental Health in 2016 and as a National Specialist Mental Health Pharmacist Advisor for Medicines in Mental Health. Prior to joining NHS England, Peter was the Chief Pharmacist at Sheffield Health and Social Care NHS Foundation Trust. He has extensive experience of psychopharmacology and pharmacy practice in mental health throughout the UK. He is a former chairperson and a fellow of the College of Mental Health Pharmacists and a fellow of the Royal Pharmaceutical Society. Peter is committed to supporting patients and prescribers achieve individualised and ‘best use’ of medicines in mental health. He has helped shape the national guidance for medicines use in mental health through his membership of several National Institute for Health and Care Excellence clinical guideline development groups including schizophrenia, the management of violence and psychosis with substance misuse.
National specialty adviser for mental health pharmacy
Matthew Elswood has been Chief Pharmacist of Nottinghamshire Healthcare NHS Foundation Trust since 2015 and has overseen a significant modernisation and transformation agenda over the last 6 years.
Matt also works as part of the University of Nottingham Pharmacy School, as an Honorary Associate Professor, where he is passionate about supporting the next generation of Pharmacists to have better knowledge and skills about Mental Health, and challenging stigma. Matt lectures routinely in the Central Nervous System and Optional Mental Health modules.
Previously Matt has served as a member of the Council of the College of Mental Health Pharmacy (CMHP) and a member of the Hospital Expert Advisory Group of the Royal Pharmaceutical Society (RPS).
Matt still works as a clinician, running innovative medication review clinics as a pharmacist prescriber in an Adult Community Mental Health Team. Matt’s work with the Rushcliffe Local Mental Health Team was recently featured in a Rethink Mental Illness publication: Keep Thinking Differently.
Outside of work Matt is a passionate Yeovil Town fan, despite being in exile in the West Midlands; and a DJ with a monthly residency in Coventry.
National specialty adviser for metabolic disorders
Dr Robin Lachmann is a Consultant in the Charles Dent Metabolic Unit at University College London Hospitals, one of the largest services in the world caring for adults with inherited metabolic diseases. He is also clinical lead of one of the national Highly Specialised Lysosomal Storage Disorder Services. He is a member of the Fetal, Maternal and Child Health Reference Group of the National Screening Committee. He has an interest in the development and implementation of rare disease policy as a member of the Rare Diseases Advisory Group and the UK Rare Diseases Forum.
Robin trained in General Internal Medicine and Metabolic Medicine and has a PhD in developing viral vectors for gene delivery to the brain.
Robin chairs the Scientific Committee of the Recordati Rare Diseases Foundation, which provides training and education in rare diseases all over the world.
National clinical director for musculoskeletal
Andrew Bennett is a Consultant Musculoskeletal Physiotherapist within Sutton Health and Care Alliance and Epsom and St Helier NHS Trust. He qualified in 2000 in Leeds, completing specialty training across London as well as a PGcert, PGdip and MSc. He led the successful re design of MSK local services presented nationally and internationally, is a lead for MSK transformation within the South West London Health and Care Partnership and acted an expert specialist for a variety of projects including the recent NIHR Moving Forward themed review. He is an undergraduate and post graduate educator and co-chair of the UK Consultant Physiotherapists group.
National specialty adviser for neonatal critical care
Dr Ngozi Edi-Osagie was appointed as a Consultant Neonatologist in 2002, is an honorary senior lecturer at the University of Manchester and Group Associate Medical Director at Manchester University Hospitals Foundation Trust.
She has broad clinical and leadership experience, having been clinical lead, clinical director
and is currently head of division of newborn services. This service encompasses a neonatal transport service, a local neonatal unit and a neonatal intensive care unit, which provides both medical and surgical neonatal activity, co-located with a tertiary children’s hospital.
She is involved in external investigations and peer review of services. She is a reviewer for MBRRACE–UK, Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK. She is also the clinical advisor for the Caribbean and African health Network and is the Officer for Genomics at the Royal College of Paediatrics and Child Health.
National clinical director for neurology
Dr Nirmalananthan is a Consultant Neurologist at St George’s University Hospitals NHS Foundation Trust and Honorary Senior Lecturer at St George’s University of London.
He was Clinical Lead for neurology and neurophysiology at St George’s Hospital from 2016 to 2019 and has been Clinical Director for Neurosciences at the Trust since 2019. He also set up and co-chairs the South West London and Surrey Neurosciences Network – leading regional collaboration and transformation from community through to tertiary care within the newly established ICSs.
He is committed to delivering integrated and networked neuroscience services with a focus on reducing inequalities in access to specialised care. In recent years, he has worked closely with South London Specialised Services Board and NHS England Neurosciences Transformation Programme to develop models for delegation of specialised neurology services.
National clinical director for neurosurgery and spinal surgery
Mr David Cumming is a fellowship-trained orthopaedic spinal surgeon with over ten years’ experience as a Consultant in Ipswich Hospital, East Suffolk & North Essex NHS Trust. His clinical practice is based around adult degenerative conditions as well as emergency spinal services. As well as being a spinal surgeon he has been involved in commissioning and clinical leadership at local, regional and national levels.
David was the Clinical Lead for MSK services in Ipswich and East Suffolk for five years. During that time, he implemented significant transformation change for elective services to improve patient access, referral pathways and clinical efficiency. He has also been Chair of the East of England Regional Spinal Network and the Clinical Lead for the MSCC working group with the Cancer Alliance in the East of England.
Mr Cumming is the current President of the British Association of Spinal Surgeons (BASS). Prior to this, he was the secretary of BASS for six years. During his time on the BASS executive, he has been involved with the society in developing guidelines, patient information and organising national meetings.
National specialty adviser for nuclear medicine
Dr Wai Lup Wong is a Consultant Radiologist in Nuclear Medicine at Lister and Mount Vernon hospital. PET-CT clinical lead Strickland scanner centre Northwood.
Wai Lup is actively involved in the development of national quality standards and clinical guidelines. He is an Expert Advisor for the NICE Centre for Clinical Practice. He is a co-author and contributor to the current “Evidence based indications for the use of PET-CT 2022”.
He has a longstanding interest in Nuclear Medicine research. He was imaging lead in the PETNECK and PETPANC trials. He is PET-CT lead in the PET-CT guided patient initiated surveillance versus clinical follow up in head and neck cancer [PETNECK 2] NCRI trial. In collaboration with Birkbeck school of Management various health care projects including analysis of the impact of COVID-19 on NHSE PETCT services and also research into organisational learning within the NHS.
National specialty adviser for obstetrics
Professor Donald Peebles has been a Professor of Maternal Fetal Medicine at UCL since 2008 and Divisional Clinical Director for Women’s Health at UCLH for the last 5 years. He is subspecialty accredited in Maternal- Fetal Medicine and works mainly in the area of Fetal medicine with special interests in fetal therapy and neurodevelopment. His main grant funding relates to developing novel methods of fetal therapy including gene therapy for fetal growth restriction. He has published over 100 peer-reviewed papers. In 2013 he was appointed as co clinical Director for the NHS England London Maternity Strategic Clinical Network, since when he has worked to improve perinatal outcomes, reduce maternal mortality rates in London, as well as to improve women’s experience of maternity services. In 2019 he was part of a team that won a BMJ Clinical Leadership award for setting up a service to treat fetal spina bifida in utero.
National specialty adviser for personalised maternity care
Dr Alison Wright is NSA Personalised Maternity Care for NHS England with a particular remit for personalised care. Alongside Matthew Jolly (NCD) and the other NSA’s in Obstetrics and Gynaecology (Janice Rymer, Misha Moore and Donald Peebles), she advises and contributes to national guidance on all aspects of women’s health.
Alison is a Consultant Obstetrician and Gynaecologist at the Royal Free Teaching Hospital in London and her clinical interests include urogynaecology, high risk obstetrics, intra-partum care, infectious diseases in pregnancy, and childbirth related trauma. She is the immediate past Vice-President of the RCOG, and as such, led a programme of work ‘Supporting our doctors’. This service provides practical support to doctors who are experiencing stress, burnout, or other difficulties in the workplace. Alison now sits on the council of the GMC and works with the GMC on initiatives including ‘supporting a profession under pressure’. Alison has a long track record of working with service users and leads workstream 3 of the maternity transformation programme (personalization). She also inputs to the personalised care institute’s programme of training in personalized care. Her particular focus currently is on the ‘I decide’ decision making tool, which has arisen form a need to improve information giving, communication and safety in intrapartum care, following the case of Nadine Montgomery. Alison also advises on global women’s health, via FIGO and WHO.
She is committed to improving services for women by collaboration, supporting provision of evidence-based care, high quality training, and involving women themselves in their care.
National specialty adviser for obstetrics (public health)
Dr Misha Moore is a consultant obstetrician at the Royal London Hospital, Barts Health, where she is lead obstetrician for perinatal mental health and public health. She is dual trained and a fully qualified public health specialist. She has worked in a variety of settings across the NHS and wider public sector, as well as the third sector. Misha is passionate about health promotion, preventative care and reducing inequalities in maternity services and women’s health. She has a particular interest in fostering integration across the health system.
National clinical director for older people and integrated person-centred care
Dr Adrian Hayter has been a GP in the Windsor area for nearly 20 years and a Clinical Commissioning Chair for Windsor Ascot and Maidenhead CCG since it’s authorisation without condition in April 2013. He has previously supported the Primary Care Commissioning agenda in roles relating to Older age care and represented health on local Older age partnership boards in both PCGs and PCTs as well as supporting local Falls initiatives in East Berkshire. He has supported the development of “A new vision of care” locally and leads work on frailty within the Frimley integrated care system. He is currently a board member of NHSCC which supports clinical commissioning at national level He continues to provide GP services for patients of his practice and has in the past contributed to the development of a local out of hours GP service as a Medical Director. His overall passion is to effect change by working as a Collaborative Leader building communities with a healthier future.
National specialty adviser for older people and integrated person-centred care
Dr Eileen Burns has been a geriatrician in Leeds for twenty-two years, was clinical director for a large teaching hospital department in the first decade of the noughties and is currently clinical lead for integration in Leeds. She is well known amongst those BGS members who have been active on the Society’s various committees, having served on several of these over the years. She currently sits on the Policy and Communications Committee and she has contributed to numerous consultations on behalf of the Society. She has also served as Chairman of the Community Geriatrics Special Interest Group for many years, presiding over one very successful stand alone community geriatrics event and several parallel sessions on the subject at our scientific meetings.
As a geriatrician dedicated to taking the specialty into the community, Eileen cites effective comprehensive geriatric assessment and close collaboration with community colleagues as central to ensuring high quality care for older people and obviation of unnecessary admission to hospital. She believes that this teamwork, and the rewards that it brings, needs to be promoted among potential specialist trainees
National specialty adviser for paediatric critical care
Dr Ruchi Sinha is a member of the Royal College of Paediatrics and Child Health and is currently a Consultant Paediatric Intensivist at St Mary’s Hospital in London. In addition to her clinical role she has been the co- lead for paediatric critical care for the North Thames Paediatric Network and is currently the co- lead for governance within this ODN.
Dr Sinha has led on the development of a consent process for Long Term Ventilation (LTV) as part of the collaborative pan London ethical framework for LTV. Dr Sinha also represented paediatric critical care during the pandemic as part of the RCPCH COVID-19 expert advisory group. During this time, she also worked collaboratively with the Paediatric Critical Care Society to develop COVID-19 guidance for paediatric intensivists. She is also on the RCPCH Bronchiolitis Steering Group. Her other main interest is in infectious disease and she is currently the paediatric critical care lead for Airborne High Consequence Infectious Diseases (HCID) at Imperial.
National specialty adviser for paediatric neurosciences
Dr Charlie Fairhurst has been a Consultant in Neurodisability for over 20 years, and is still constantly re-appraising and re-designing movement therapy services learning from the children & families.
Charlie has been Head of Service at the Evelina for 6 years and has developed clear pathways and partnerships with referrers & regional colleagues in adult and paediatric neurological, medical, and surgical teams.
He has also been involved with NICE, both as a chair and now as a clinical advisor, on Women’s and Children’s Health and Social Care guideline development. He has been at the forefront in improving the evidence base for assessments and interventions in children and young people with disability. As such, in recognition of his work as a principal investigator, he was given a special award for innovation by NIHR, in 2015.
National specialty adviser for pathology
Professor Joanne Martin is a practising histopathologist at the Royal London Hospital. Her clinical specialist expertise is in the pathology of gastrointestinal motility disorders and in renal pathology. She is Professor of Pathology at Queen Mary University London, with research interests in new diagnostics and drug delivery. She chairs the Research Advisory Board of the Motor Neuron Disease Association. She led education and research across Barts Health NHS Trust, and has created app based training tools for staff, students, patients and carers.
Jo has wide experience of healthcare management and leadership in a range of positions, including the Board of Barts Health NHS Trust. She has worked across programmes and projects in all the pathology disciplines including genetics, transfusion, digital pathology, data, networks and with many professional bodies and patient groups. National Clinical Director of Pathology for NHS England April 2013-16, Jo became President of the
National specialty advisor for perinatal mental health
Dr Giles Berrisford is the clinical lead for perinatal mental health services across Birmingham, Solihull and the Black Country and is committed to the development of perinatal mental health services locally and nationally. He has been the consultant psychiatrist on the Birmingham Mother and Baby Unit since 2009.
He is the Chair of the National Clinical Reference Group for Perinatal Mental Health and has been since 2016 and was the former Associate National Clinical Director for Perinatal Mental Health prior to commencing this role as National Specialty Advisor to NHS England.
He has been the Chair of the national charity Action on Postpartum Psychosis since 2014 – the only national charity dedicated to supporting women and families affected by the most severe form of perinatal mental illness – postpartum psychosis. He is keen to ensure that experts with lived experience are involved and central to service developments at all levels.
National clinical director for critical and peri-operative care
Professor Ramani Moonesinghe is Professor of peri-operative medicine at University College London. She trained in medicine, anaesthesia and critical care in London and works clinically at University College Hospital. She is Director of the national Health Services Research Centre at the Royal College of Anaesthetists and head of her research department at UCL; her research focuses on health services research, improvement based research and clinical trials in perioperative and critical care in the UK and overseas.
National specialty adviser for physiological measurements
Martin Allen is a Respiratory Physician at University Hospital of North Staffordshire. He has interests in a variety of respiratory diseases including COPD, ventilatory support/weaning and sleep medicine originating from my research into sleep and physiological changes. He has fulfilled a variety of management and transformational roles within the hospital, including CD and Medicine Divisional Head. Holding a variety of national roles he sits on the British Thoracic Society Board, Chairs the respiratory EWG on coding, sits on the Respiratory CRG, contributes to the Respiratory Long Term Plan and is the GIRFT National Clinical Lead for Respiratory Medicine.
National clinical director for prescribing
Professor Avery OBE is a GP in Nottingham and Professor of Primary Health Care at the University of Nottingham. He is also a National Institute for Health Research (NIHR) Senior Investigator and member of the NIHR Greater Manchester Patient Safety Translational Research Centre. He was awarded an OBE in the 2022 New Year’s Honours list.
He is passionate about ensuring the safe, effective and appropriate use of medicines and has worked in partnership with the pharmacy professions, other healthcare professionals and patients over 30 years to drive forward research and policy development in prescribing and patient safety.
He has led a number of major studies investigating the frequency, nature and causes of prescribing safety problems in the NHS. He has also developed effective methods for tackling hazardous prescribing, most notably the pharmacist-led, IT-based intervention called PINCER, which has now been rolled out nationally to general practices in England.
Tony’s work recognises the vital role that medicines have in treating illness and helping people live with long-term conditions, while acknowledging that prescribing of a medicine is not always the best solution. He is committed to ensuring health care professionals and patients have the information and support they need for shared decision making about whether a prescription is needed and, if so, how to balance the effectiveness and safety of medicines alongside the costs to the patient, the NHS and the environment.
National specialty adviser for proton beam therapy
Dr Adrian Crellin is a Consultant Clinical Oncologist in Leeds and Honorary Associate Clinical Professor, University of Leeds. He is NHS England’s National Clinical Lead for Proton Beam Therapy. He is Chair of NHS England’s Highly Specialised Commissioning Proton Referral Programme National Clinical Reference Panels. He Chairs the Public Health England Radiotherapy Information Strategy Group.
He is a trustee of Cancer Research UK, also being a member of both Council and Research Committees.
He was Vice-President of the Royal College of Radiologists and Dean of the Faculty of Clinical Oncology and is a former Clinical Director at the Institute of Oncology in Leeds.
National specialty adviser for public health screening
Dominic Horne is a GP in Herefordshire and Honorary Senior Lecturer at the University of Worcester. He has recently completed a Masters in Public Health at the University of Warwick. Dominic is a member of the RCGP Midland Faculty Board and the West Midlands Clinical Senate, a Trustee at the Self Care Forum, a charity based in London, and works with NICE and the Clinical Research Network. He is committed to patient safety, public involvement and reducing health inequalities.
National specialty adviser for radiotherapy
Dr Imogen Locke was appointed a Consultant in Clinical Oncology at The Royal Marsden NHS Foundation Trust (RMH) in 2007 where she specialises in breast and lung cancer radiotherapy. She was the Lead for Clinical Oncology at RMH between 2013 and 2018 and a member of the RMH Clinical Executive Board between 2016 – 2018.
She was a previous Chair of the Clinical Oncology Audit Committee of the Royal College of Radiologists (RCR) and the RCR Quality Improvement Lead. She has designed and led 3 national RCR audits of breast radiotherapy practice. She was a member of the NICE Early Breast Cancer Guideline Committee producing updated guidelines published in 2018. She was the Chair of the Radiotherapy Clinical Reference Group from 2019 to 2022 prior to her current appointment as National Speciality Advisor.
Her clinical interests are advanced breast radiotherapy techniques and ensuring patients receive risk adapted radiotherapy treatment. She is also the Principal Investigator of a randomised study evaluating acupuncture as a treatment for Long COVID-19 related fatigue (ACU-COVID-19).
National specialty adviser for rehabilitation, disability and spinal cord injury
Dr Krystyna Walton is a Consultant in Rehabilitation Medicine and the Clinical Director for Neurorehabilitation in the Manchester Centre for Clinical Neurosciences, based at Salford Royal Hospital in Greater Manchester (Northern Care Alliance NHS Foundation Trust).
Strategically Krystyna led the development of the Greater Manchester model for Neurorehabilitation in the late 1990’s. This was an innovative model of co-ordinated Neurorehabilitation provision integrated with Neuroscience provision.
Evolution of the model has continued over the years and now includes spinal cord injury services for patients who are unable to access spinal cord injury centre care. Krystyna was the clinical lead for Transformation of Neurorehabilitation services in Greater Manchester for 3 years from 2017, during which time an updated model of care was developed and agreed with clinicians, patient/carer representatives and commissioners.
National clinical director for renal services
Professor Smeeta Sinha is a Consultant Nephrologist at Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust and a Visiting Professor at Manchester Metropolitan University. She was the Clinical Director for Renal services at Salford Royal between 2014 and 2020 and oversaw the delivery of kidney care centres across the North of Greater Manchester. These kidney care centres have enabled patients to receive kidney care closer to home. Smeeta was also the North West Kidney Network Clinical Lead between 2020 and November 2022. Smeeta is the NHS England Clinical Lead and CKD lead for the NHS England Renal Service Transformation Programme.
Smeeta’s clinical interests are in CKD, multimorbidity and glomerulonephritis. She leads the complex glomerulonephritis service at Salford Royal which is an integrated clinical and research clinic serving a population of 1.3 million. Smeeta’s research interests include chronic kidney disease-mineral bone disorder, in particular vascular calcification, glomerulonephritis and rare renal diseases.
National specialty advisor for secure mental health
Dr Mayura Deshpande is a consultant forensic psychiatrist and associate Medical Director at Southern Health Foundation Trust. She has also been clinical lead of the national network of adolescent medium secure units on behalf of NHS England for the past four years.
National specialty advisor for specialised blood disorders
Dr Susie Shapiro is a Consultant Haematologist and works entirely in the field of haemostasis and thrombosis: haemophilia and other bleeding disorders, thrombosis and anticoagulation at Oxford University Hospitals. She has particular interest in improving patient safety, with projects to optimise anticoagulation winning national awards; and in improving knowledge of aging and comorbidities in haemophilia including with respect to new innovative treatments.
Dr Shapiro is currently Head of Department for the Oxford Haemophilia and Thrombosis Service, having previously been Director of the Oxford Haemophilia Service 2018-2022 and hospital leads for both Venous Thromboembolism (VTE) prevention and anticoagulation. She has been a member of the Clinical Reference Group for Specialised Bleeding Disorders since 2019, Secretary of the UK Haemophilia Centre Doctors Organisation, member of the Medical and Scientific Advisory Group for the UK Haemophilia Society, and Co-Chair of the Scientific Sub Committee on FVIII, FIX and Rare Coagulation Disorders for the International Society of Thrombosis and Haemostasis.. She is also an Associate Professor of Haematology at Oxford University.
National specialty advisor for specialised immunology and allergy
Dr Claire Bethune has been a Consultant Immunologist at University Hospitals Plymouth since 2004 and has been clinical lead for the regional service since 2012. She has developed the service to provide the full range of specialised allergy and immunodeficiency investigations and treatments for patients in the South West Peninsula. An enthusiastic teacher she is training program director immunology/allergy for Peninsula and Severn Deaneries as well as having various leadership roles in Peninsula Medical School. She has been principal investigator for a number of national and international clinical trials and following the successful local leadership of vaccine studies during the pandemic she was invited to become regional CRN vaccine trial lead.
Since 2015 Claire has led the RCP program for accreditation of immunology services as well as establishing and leading the annual census of immunodeficiency services. She also led the guideline writing group for the UK primary immunodeficiency network and British society of immunology leading to the publication of national guidelines.
National specialty advisor for specialised paediatric renal services
Dr Daljit Hothi is a Consultant Paediatric Nephrologist at Great Ormond Street Hospital (GOSH) and a self-declared enthusiast for paediatric dialysis. She leads the largest International Paediatric Home Haemodialysis Programme; has mentored colleagues establishing their HHD services; published, presented and written book chapters on HHD; and has become a recognised global expert and ambassador.
Over the years Dal has held many local, regional and national leadership roles. Currently she is Associate Medical Director Quality for Wellbeing, Leadership & Improvement at GOSH; the Officer for Life-Long Careers at the RCPCH; and Director of Leadership Development & Education at the FMLM.
Over the past 12 years she has been developing a profile in leadership and coaching. She was a faculty member of the NHS Staff College for 4 years and trained Action Learning Set facilitator by the Leadership Academy. She is now the Director of Leadership Development & Education at the FMLM.
National specialty adviser for specialised rheumatology
Dr Shouvik Dass is a Consultant Rheumatologist at the Leeds Teaching Hospitals NHS Trust. He has held this post since 2009 and has been Lead Clinician for Rheumatology at Leeds since 2015. His specialist clinical and research interests are in complex connective tissue diseases (particularly lupus and vasculitis) and rheumatoid arthritis, with a focus on novel targeted therapeutics and developing associated treatment algorithms. He also has lead roles in the regional rheumatology obstetrics and lung diseases services and in national projects in these areas.
He has been a member of the NHS England Clinical Reference Group for Specialist Rheumatology since 2016 and is one of the chief co-ordinators of the Yorkshire Rheumatology Network. He has a role in national networks that are developing and reviewing new models of care across Rheumatology. He has also been the Training Programme Director for Rheumatology in North, East and West Yorkshire since 2016.
National clinical director for stroke
Dr Deborah Lowe is a stroke physician at Wirral University Teaching Hospital and Clinical lead for stroke for the Northwest Coast Strategic Clinical Network. She is also the national clinical lead for stroke medicine for the Getting It Right First Time programme, and through this role has already visited more than half of hospital stroke services in England.
National specialty adviser for stroke
David Hargroves is a consultant stroke physician in East Kent, graduating from University College London, with a Masters from Kings following a stroke research thesis during his general medicine, geriatric and stroke fellowship training.
He is clinical lead for the Getting it Right First Time (GIRFT) stroke programme for NHS England and Improvement and has met over 200 acute and rehabilitation stroke teams in 2019 and has co-written the GIRFT national stroke report which is due for publication 2021.
David co-produced the National Stroke Service Model (NSSM) and the National Optimal Stroke Imaging Pathway (NOSIP), which incorporates the use of Artificial Intelligence software as a decision support aid, which were both published May 2021. He has published pragmatic guidance with colleagues from the Oxford Academic Health Science Network on adaption of stroke services during the COVID 19 pandemic, including resources to assist systems to improve the detection of modifiable vascular conditions.
He is the holder of the Life after Stroke Award for Professional Excellence from the Stroke Association.
National specialty adviser for surgery in children
Dr Sujata De is a Paediatric ENT surgeon at Alder Hey Childrens Hospital in Liverpool. Her clinical interests include Paediatric Airway surgery, Microtia, Bone Conducting hearing Implants and the ENT care of Children with Downs syndrome and Craniofacial syndromes. She is a Fellow of the Royal College of Surgeons of England and an active member of ENTUK and the British Association of Paediatric Otolaryngology.
She is currently Co- Clinical lead of the Northwest Surgery in Children Operational Delivery Network. She is passionate about fairness (Staff Governor, LNC member) and equity of access to healthcare, teaching and training (Senior Lecturer, University of Liverpool, examiner for the Fellowship of the Roy-al College of Surgeons), wellbeing (Trainee Supported Return to Training and Wellbeing Lead) and celebrating and enabling women in the workplace.
She believes that setting clear standards and collaboration between healthcare providers including primary, non-specialised and specialised, will enhance the quality of surgical care that is provided to children, young people and their families.
National specialty adviser for tobacco addiction
Professor Sanjay Agrawal has been a Consultant in Respiratory and Intensive Care Medicine for over 20 years. He has Chaired the British Thoracic Society (BTS) tobacco specialist advisory group and co- led the 2016 BTS national hospital tobacco audit. In 2018 he co-edited the Royal College of Physicians (RCP) report ‘Hiding in plain sight: treating tobacco dependency in the NHS and Chairs the RCP Tobacco advisory group. Dr Agrawal is a member of the Public Health England Implementation Board for The Tobacco Control Plan for England and has served on the NICE Public Health Advisory Committee producing recommendations for the prevention and treatment of tobacco dependency.
National specialty adviser for trauma
Robert Bentley is a fulltime Craniofacial and Oral and Maxillofacial Surgeon with a special interest in cranial reconstruction, and skull base surgery. Having completing his CCT in Oral and Maxillofacial Surgery (OMFS) in 1999 he went on to gain fellowships in paediatric and adult Craniofacial surgery at the University of Birmingham, Leipzig, Heidelberg and Basel.
Robert has published widely and taught internationally on craniofacial trauma and was training programme director for OMFS for London from 2008-18, and was President of the British Association of Oral and Maxillofacial Surgeons in 2020.
National clinical director for urgent and emergency care
Professor Julian Redhead was first appointed as a consultant in Emergency Medicine at Ealing hospital in 2000. He joined Imperial College Healthcare NHS Trust full time in 2004 and became chief of service for emergency medicine in 2008.
Since then he has held various roles within Imperial, including clinical programme group director for medicine, divisional director for investigative and supporting sciences, associate medical director for professional development and interim chief executive. Since 2016 he has been medical director for Imperial Healthcare and since 2018 has combined this role with medical director of the North West London Integrated Care Partnership. He was awarded Professor (of Practice) Emergency Medicine and Sports Science by Imperial College in 2017.
He is currently secretary and trustee for the British Association of Immediate Care (London), a Care Quality Commission inspector and trustee for the Royal Society for the prevention of accidents (ROSPA). Previously he was Chair of the London Board and council member for the Royal College Emergency Medicine, a major incident response doctor for London ambulance Service, and a clinical lead for the Improving Partnership in Hospitals programme.
National specialty adviser for vascular disease
Professor Robert Sayers is the George Davies Chair of Vascular Surgery at University of Leicester and Honorary Consultant Vascular and Endovascular Surgeon at Leicester Vascular Institute, Glenfield Hospital, Leicester. He is a Past President of the Vascular Society of Great Britain and Ireland (2016-17) and former Chair of the Research Committee of the VSGBI. He has an extensive research portfolio in the fields of AAA and now CLTI. He has been a council member and chair of the programme committee for SARS and council member and chair of the fellowship committee for BSET.
He was a member of the Intercollegiate Examination Board and has examined in Vascular and General Surgery and Anatomy at both MRCS and FRCS level. He has led a number of service reviews into reconfiguration and commissioning of vascular services, including advising on national delivery of services during the COVID-19 pandemic. He also serves on the Council of the Royal College of Surgeons of England as specialty lead for Vascular Surgery.
National clinical director for violence reduction
Martin Griffiths is a consultant Trauma and Vascular Surgeon at Barts Health NHS Trust where he developed the nation’s first ward-based intervention programme for the victims of interpersonal injury. He is also the Clinical Director for the Violence Reduction Network in NHS London and has led the expansion of the public-health approach to violence reduction in the capital. He has an interest in integrating peer groups in the co-design of community and healthcare-based prevention and education programmes.